TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35485814

Group type: EXPERIMENTAL
Intervention: Radio wave electrotherapy (448 kHz)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 61
Study: 35127522

Group type: EXPERIMENTAL
Intervention: High OC/OL‐EVOO (40 ml/day, 416 mg/Kg OC and 284 mg/kg OL for 3 months)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High OC/OL‐EVOO (40 ml/day for 6 months)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Low OC/OL (40 ml/day, 82 mg/kg OC and 33 mg/kg OL for 3 months)
Number of subjects: 20
Study: 35229548

Group type: EXPERIMENTAL
Intervention: Pomegranate peel extract (PoPEx) 250 mg twice daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo capsules twice daily
Number of subjects: 30
Study: 33616555

Group type: EXPERIMENTAL
Intervention: 0.2% sodium hypochlorite (SH) for 20 minutes
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Efferdent for 3 minutes
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 6.25% Ricinus communis (RC) for 20 minutes
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.85% saline solution for 20 minutes (control)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Brush immersion in solutions (SH, Efferdent, RC)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: SH and Efferdent
Number of subjects: 45
Study: 32827035

Group type: EXPERIMENTAL
Intervention: Transcriptome-wide association study (TWAS) for total body BMD (TB-BMD)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Summarized mendelian randomization analysis
Number of subjects: 66

Group type: COMPARATOR
Intervention: Previous GWASs or TWASs for osteoporosis
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Novel genes identified
Number of subjects: 66
Study: 35241394

Group type: EXPERIMENTAL
Intervention: 6‐wk intensive smoking and/or alcohol cessation intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 104
Study: 33577586

Group type: EXPERIMENTAL
Intervention: Sit-to-stand test (STST)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Six-minute walk test (6MWT)
Number of subjects: 36
Study: 32172681

Group type: EXPERIMENTAL
Intervention: Mindfulness-based yoga instruction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Appearance-based yoga instruction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Neutral yoga instruction
Number of subjects: 62
Study: 33971939

Group type: EXPERIMENTAL
Intervention: Whole School SEND Review intervention
Number of subjects: 58000
Study: 32638035

Group type: EXPERIMENTAL
Intervention: Escitalopram (20 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 32229610

Group type: EXPERIMENTAL
Intervention: Polygenic Mendelian Randomization methods
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Polygenic score as an instrument
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outlier detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bayesian approaches
Number of subjects: 0
Study: 33243791

Group type: EXPERIMENTAL
Intervention: Nurse-led, screening-Triggered, early specialised palliative care intervention programme
Number of subjects: 206

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 206
Study: 34156129

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sunflower oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Poultry oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Milk thistle meal (30 g/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fat powder
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Poultry oil, sunflower oil, fish oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fish or sunflower oil
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Poultry oil and milk thistle meal (30 g/kg)
Number of subjects: 60
Study: 34289823

Group type: EXPERIMENTAL
Intervention: Nintedanib 50-150 mg BID
Number of subjects: 2742
Study: 36333296

Group type: EXPERIMENTAL
Intervention: Peanut oral immunotherapy (OIT)
Number of subjects: 120
Study: 32271500

Group type: EXPERIMENTAL
Intervention: Let's Talk about Children intervention
Number of subjects: 73
Study: 36247420

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg a day on top of antidiabetic treatment)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no specific treatment mentioned)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg a day)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Baseline RDW
Number of subjects: 110
Study: 33326024

Group type: EXPERIMENTAL
Intervention: Traffic light system (TLS)-based educational intervention
Number of subjects: 34

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 34
Study: 33555207

Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC)
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC) with medium Zn hydroxychloride (ZHC)
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: Medium Zn hydroxychloride (ZHC)
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: High Cu sulphate monohydrate (CSM) with high Zn sulphate monohydrate (ZSM)
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: Low Cu hydroxychloride (CHC) with low or medium Zn hydroxychloride (ZHC)
Number of subjects: 1792

Group type: EXPERIMENTAL
Intervention: High Cu hydroxychloride (CHC) and low Zn hydroxychloride (ZHC)
Number of subjects: 1792
Study: 32306085

Group type: EXPERIMENTAL
Intervention: 3 weeks of balneotherapy (daily whirlpool baths, hydrokinesitherapy sessions, knee shower/massages)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (usual analgesia medication only)
Number of subjects: 120
Study: 35333744

Group type: EXPERIMENTAL
Intervention: Alfaxalone (5 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alfaxalone (5 mg/kg) and midazolam (0.5 mg/kg)
Number of subjects: 24
Study: 33236087

Group type: EXPERIMENTAL
Intervention: Two randomly selected leaves from the middle stratum
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Standard uppermost + lowermost leaf sample unit (L1+U1)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Other sample units
Number of subjects: 140
Study: 32653577

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 35
Study: 34881641

Group type: EXPERIMENTAL
Intervention: CYP2C19 testing
Number of subjects: 0
Study: 34090603

Group type: EXPERIMENTAL
Intervention: Upadacitinib 30 mg once daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33177724

Group type: EXPERIMENTAL
Intervention: Fast-track rehabilitation nursing (study group 1)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Fast-track rehabilitation nursing (study group 2)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Routine nursing (control group)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Pain control (all groups)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Satisfaction with pain control (all groups)
Number of subjects: 82
Study: 35871931

Group type: EXPERIMENTAL
Intervention: Intuitive Eating Group (IEG; n=23)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Intuitive Eating and Nutritional Guidelines Group (IEGDG; n=17)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control Group (CG; n=18)
Number of subjects: 58
Study: 35029099

Group type: EXPERIMENTAL
Intervention: Double-layer composite resin teeth (Group 2)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional composite resin teeth (Group 1)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 20
Study: 32707403

Group type: EXPERIMENTAL
Intervention: Wheeled knee walker (WKW)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Walker
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Crutches
Number of subjects: 21

Group type: COMPARATOR
Intervention: No assistive device (control condition)
Number of subjects: 21
Study: 35614488

Group type: EXPERIMENTAL
Intervention: Upper arm self-sampling device (UA)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Finger prick-test (FP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Venous blood sampling (VBS)
Number of subjects: 50
Study: 33822227

Group type: EXPERIMENTAL
Intervention: SO-DCS (anodal suboccipital direct current stimulation)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: M1-DCS (anodal motor cortex direct current stimulation)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham DCS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: SO-DCS and M1-DCS
Number of subjects: 40
Study: 34134024

Group type: EXPERIMENTAL
Intervention: ReVeRe.D (iPad-administered cognitive test battery)
Number of subjects: 244

Group type: COMPARATOR
Intervention: examiner-administered tests
Number of subjects: 244
Study: 32067625

Group type: EXPERIMENTAL
Intervention: Propranolol-based standard care
Number of subjects: 85

Group type: COMPARATOR
Intervention: Rifaximin and standard care
Number of subjects: 85
Study: 36470699

Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (noise reduction)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 33710288

Group type: EXPERIMENTAL
Intervention: Active iTBS (120% resting motor threshold)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Sham iTBS
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Open-label iTBS (after double-blind phase)
Number of subjects: 37
Study: 32546128

Group type: EXPERIMENTAL
Intervention: Videolaryngoscopy (GVL)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Direct laryngoscopy (DL)
Number of subjects: 65
Study: 32729280

Group type: EXPERIMENTAL
Intervention: Direct access to hospitals for HCV-positive participants
Number of subjects: 351

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: PoC HCV screening with direct access referral
Number of subjects: 351
Study: 33577181

Group type: EXPERIMENTAL
Intervention: Dye-based chromoendoscopy (CE)
Number of subjects: 533

Group type: COMPARATOR
Intervention: White light endoscopy (WLE)
Number of subjects: 533
Study: 35332045

Group type: EXPERIMENTAL
Intervention: School-based and primary care-based multicomponent intervention including education and motivation at school, training for general practitioners, and free vaccination access.
Number of subjects: 41940

Group type: EXPERIMENTAL
Intervention: School-based and primary care-based multicomponent intervention.
Number of subjects: 41940
Study: 32202163

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention with standard care plus 12 MI sessions within 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Standard care only (Control)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) intervention
Number of subjects: 25
Study: 34537802

Group type: EXPERIMENTAL
Intervention: B100R (100% braking load reduction during landing with release at touchdown)
Number of subjects: 22

Group type: COMPARATOR
Intervention: B0 (traditional load, no braking)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: B25 (25% braking load reduction during landing)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: B50 (50% braking load reduction during landing)
Number of subjects: 22
Study: 33081705

Group type: EXPERIMENTAL
Intervention: Telehealth Cognitive-Behavioral Therapy for Insomnia (CBT-I)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 126

Group type: COMPARATOR
Intervention: Medication placebo
Number of subjects: 126
Study: 35768092

Group type: EXPERIMENTAL
Intervention: Radial pulse palpation
Number of subjects: 4339

Group type: EXPERIMENTAL
Intervention: Electronic blood pressure measurement (WatchBP Home A)
Number of subjects: 4339

Group type: EXPERIMENTAL
Intervention: Handheld ECG (MyDiagnostick)
Number of subjects: 4339
Study: 34600464

Group type: EXPERIMENTAL
Intervention: Minocycline combined with tinidazole
Number of subjects: 73

Group type: COMPARATOR
Intervention: Minocycline alone (control group)
Number of subjects: 73
Study: 32183555

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (AE)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Control
Number of subjects: 139
Study: 32660657

Group type: EXPERIMENTAL
Intervention: Mycoprotein (MYC) as the primary source of dietary protein
Number of subjects: 20

Group type: COMPARATOR
Intervention: Meat/fish (control group, CON) as the primary source of dietary protein
Number of subjects: 20
Study: 32313279

Group type: EXPERIMENTAL
Intervention: Teaching a diabetes self-management education and support (DSMES) class
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (did not teach a DSMES class)
Number of subjects: 46
Study: 32955232

Group type: EXPERIMENTAL
Intervention: Action approach towards a child’s chronic disease
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Age of parents
Number of subjects: 107

Group type: COMPARATOR
Intervention: Place of residence of parents
Number of subjects: 107
Study: 33883890

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol via ELLIPTA DPI
Number of subjects: 1460

Group type: COMPARATOR
Intervention: Budesonide/formoterol+tiotropium
Number of subjects: 1460
Study: 33035175

Group type: EXPERIMENTAL
Intervention: eXtreme Gradient Boosting (XGBoost) model using 8 important risk factors
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Calibration curve of the XGBoost model
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: SHAP and LIME algorithms for model interpretation
Number of subjects: 123
Study: 35428298

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention (nutrition/PA)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Attention control (reading readiness/literacy)
Number of subjects: 377
Study: 34550483

Group type: EXPERIMENTAL
Intervention: Docetaxel (75 mg/m2 on day 1) and cisplatin (75 mg/m2 on day 1), repeated every 21 days for 6 cycles
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Docetaxel and cisplatin combination
Number of subjects: 23
Study: 32319955

Group type: EXPERIMENTAL
Intervention: Paper-and-pencil followed by tablet app
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Tablet only
Number of subjects: 92

Group type: COMPARATOR
Intervention: Paper-and-pencil only
Number of subjects: 92
Study: 34240285

Group type: EXPERIMENTAL
Intervention: Dyadic intervention
Number of subjects: 239
Study: 33464615

Group type: EXPERIMENTAL
Intervention: Randomized formula presented -values
Number of subjects: 0

Group type: COMPARATOR
Intervention: LFC-based approach
Number of subjects: 0
Study: 35139812

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of Ranibizumab (IVR) 1 or 3 days before vitrectomy
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intravitreal injection of Ranibizumab (IVR) 3 days before vitrectomy
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham subconjunctival injection 3 days before surgery
Number of subjects: 48
Study: 34527936

Group type: EXPERIMENTAL
Intervention: Probiotic product plus usual medical care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Probiotical sham plus usual medical care
Number of subjects: 60
Study: 34962062

Group type: EXPERIMENTAL
Intervention: Circularly polarized smartphones
Number of subjects: 120

Group type: COMPARATOR
Intervention: Linearly polarized smartphones
Number of subjects: 120
Study: 34076698

Group type: EXPERIMENTAL
Intervention: Investigator-Initiated Clinical Trials (IICTs)
Number of subjects: 48
Study: 32598904

Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 99
Study: 35733997

Group type: EXPERIMENTAL
Intervention: T2DM (untreated)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (CTRL)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: MET (metformin therapy)
Number of subjects: 24
Study: 32503663

Group type: EXPERIMENTAL
Intervention: Inhaled sargramostim 125 μg twice daily for 5 days
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 80
Study: 35665035

Group type: EXPERIMENTAL
Intervention: Functional acupuncture (FA) and routine rehabilitation treatment
Number of subjects: 108

Group type: COMPARATOR
Intervention: Traditional acupuncture (TA) and routine rehabilitation treatment
Number of subjects: 108
Study: 33397663

Group type: EXPERIMENTAL
Intervention: Evidence-based intervention guided by the HEARTS technical package, including training of NCD service providers, provision of essential equipment/supporting materials, and monthly monitoring and feedback.
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Baseline situational analysis and qualitative assessment of barriers and facilitators.
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Implementation monitoring and evaluation phase using the RE-AIM framework.
Number of subjects: 697
Study: 35314184

Group type: EXPERIMENTAL
Intervention: Intraoperative IV ketorolac (Toradol)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (no ketorolac)
Number of subjects: 94
Study: 33093013

Group type: EXPERIMENTAL
Intervention: Myofunctional therapy app
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 35148732

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid gel (HYAcorp Endogel)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ovarian suspension
Number of subjects: 50
Study: 34134794

Group type: EXPERIMENTAL
Intervention: L-citrulline (12 g)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 9
Study: 32711655

Group type: EXPERIMENTAL
Intervention: Gold nanomaterial (GNP) contrast agent used in medical imaging tests
Number of subjects: 3

Group type: COMPARATOR
Intervention: OA group (positive control)
Number of subjects: 3

Group type: COMPARATOR
Intervention: OP group (negative control)
Number of subjects: 3
Study: 36367708

Group type: EXPERIMENTAL
Intervention: Bean diet
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Potato diet
Number of subjects: 36
Study: 35942800

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (CLT)
Number of subjects: 28
Study: 37356077

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg (single dose)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 2 weeks (IXE Q2W)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Ixekizumab 80 mg every 4 weeks (IXE Q4W)
Number of subjects: 41
Study: 33587431

Group type: EXPERIMENTAL
Intervention: Preemptive antiviral therapy (PET)
Number of subjects: 96
Study: 36124667

Group type: EXPERIMENTAL
Intervention: Weekly exercise
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: Monte Carlo g-computation
Number of subjects: 1226

Group type: EXPERIMENTAL
Intervention: ICE g-computation
Number of subjects: 1226
Study: 34325040

Group type: EXPERIMENTAL
Intervention: Cognitive Enrichment Program (CEP) - 12-week, 24-session multimodal group cognitive intervention.
Number of subjects: 37

Group type: COMPARATOR
Intervention: Usual care in the form of individual holistic rehabilitation (active control).
Number of subjects: 37
Study: 33217600

Group type: EXPERIMENTAL
Intervention: Thrombin gel matrix (TGM), Floseal, applied at 5 mL to the pelvic sidewalls after lymphadenectomy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no TGM applied)
Number of subjects: 79
Study: 32005780

Group type: EXPERIMENTAL
Intervention: Peer counselling intervention with trained peer counsellors providing weekly contact and face-to-face meetings every fortnight.
Number of subjects: 2400

Group type: EXPERIMENTAL
Intervention: Peer counselling intervention
Number of subjects: 2400
Study: 36110927

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) - 60 units injected into bilateral masseter muscles
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) - 90 units injected into bilateral masseter and temporalis muscles
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTX‐A) - 120 units injected into bilateral masseter, temporalis, and medial pterygoid muscles
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 34776166

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) combined with running training (RT) for 6 weeks, 3 sessions per week, 15 min per session, 1 kHz, 50 Hz burst frequency, 10% duty cycle.
Number of subjects: 30
Study: 35608802

Group type: EXPERIMENTAL
Intervention: Primary-site locoregional therapy (PSLT)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Systemic therapy (ST)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: PSLT
Number of subjects: 4
Study: 33566072

Group type: EXPERIMENTAL
Intervention: Uncontrolled hypertension
Number of subjects: 316

Group type: COMPARATOR
Intervention: Postsecondary education
Number of subjects: 316

Group type: COMPARATOR
Intervention: Number of chronic conditions
Number of subjects: 316

Group type: COMPARATOR
Intervention: Smoking
Number of subjects: 316
Study: 36055537

Group type: EXPERIMENTAL
Intervention: tDCS (2.0 mA, 20 min duration, 10 sessions)
Number of subjects: 51
Study: 33871713

Group type: EXPERIMENTAL
Intervention: Pancreatectomy for patients aged ≥ 80 years
Number of subjects: 579

Group type: COMPARATOR
Intervention: Pancreatectomy for patients aged < 80 years
Number of subjects: 579
Study: 32211883

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir + raltegravir
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted darunavir + tenofovir disoproxil fumarate/emtricitabine
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Integrase inhibitor exposure (ritonavir-boosted darunavir + raltegravir)
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate exposure
Number of subjects: 745

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 745
Study: 35613820

Group type: EXPERIMENTAL
Intervention: Embedded physical therapy intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0